Okla. Admin. Code § 475:10-1-4 - [Effective until 9/14/2025] Separate registration

(a) Every person or entity who engages in, or who proposes to engage in, more than one group of independent activities shall obtain a separate registration for each group of activities, except as provided by this subsection. Any person or entity, when registered to engage in the group of activities described in each paragraph of this subsection, shall be authorized to engage in the coincident activities described in that subparagraph without obtaining a registration to engage in such coincident activities; provided that, unless specifically exempted, the registrant complies with all requirements and duties prescribed by law for persons or entities registered to engage in such coincident activities.

(1) A person or entity registered to manufacture any controlled dangerous substance or basic class of controlled dangerous substances shall be authorized to distribute that substance or class, but is not authorized to distribute any substance or class which the registrant is not registered to manufacture.

(2) A person or entity registered to manufacture any controlled dangerous substance listed in Schedules I through V shall be authorized to conduct chemical analysis and preclinical research (including quality control analysis) with narcotic and non-narcotic controlled dangerous substances listed in those schedules which the registrant is authorized to manufacture.

(3) A registrant authorized to conduct analytical laboratory activities with controlled dangerous substances shall be authorized to manufacture such substances for analytical or instructional purposes, to distribute such substances to other registrants authorized to conduct analytical laboratory activities, institutional instructional activities, or scientific research with such substances and to persons or entities exempted from registration provided such distribution is made in conformance with state law.

(4) A person registered or authorized to conduct scientific research with controlled dangerous substances listed in Schedules I through V shall be authorized to conduct analytical laboratory activities with controlled dangerous substances listed in those schedules in which he/she is authorized to conduct scientific research, to manufacture such substances if and to the extent that such manufacturing is set forth in the protocol filed with the application for registration, to distribute such substances to other persons or entities registered or authorized to conduct analytical laboratory activities, institutional instructional activities, or scientific research with such substances, and to persons or entities exempted from registration provided such distribution is made in conformance with state law, and to conduct instructional activities with controlled dangerous substances.

(5) Physicians, dentists, podiatrists, veterinarians, optometrists and other qualified persons who are authorized to carry on their respective activities under the laws of the State of Oklahoma and who are registered with the OBN to dispense, prescribe, and/or administer controlled dangerous substances shall be authorized to conduct instructional activities with those substances. Practitioners authorized to administer and/or dispense controlled dangerous substances are authorized to order the controlled dangerous substances for dispensation and administration.

(6) Trainers or handlers of a canine controlled dangerous substance detector who, in the ordinary course of their profession, desire to possess any controlled dangerous substance for training said canine.

(7) A single registration to engage in any group of independent activities may include one or more controlled dangerous substances listed in the schedules authorized in that group of independent activities. A person registered to conduct scientific research with controlled dangerous substances listed in Schedule I may conduct scientific research with any substance listed in Schedule I for which the registrant has filed and had approved a scientific research protocol.

(b) The following locations shall not be deemed to be principal places where controlled dangerous substances are manufactured, distributed, dispensed, and/or prescribed:

(1) A warehouse where controlled dangerous substances are stored by or on behalf of a registrant, but not used as a distribution point, does not require a separate registration. The warehouse location shall be included on the registration application but may be fee exempt at the discretion of the Director. If a warehouse location is added at any later time after the application has been submitted, the registrant shall notify OBN of such location within one (1) business day. Warehouse locations shall meet all applicable state and local laws and have the same physical security requirements as specified in Chapter 20 of this Title.

(2) An office used by agents of a registrant where sales of controlled dangerous substances are solicited, made, or supervised but which neither contain such substances (other than substances for display purposes or lawful distribution as samples only) nor serves as a distribution point for filling sales orders.

(3) An office used by a practitioner (who is registered at another location) where controlled dangerous substances are prescribed but neither administered nor otherwise dispensed as a regular part of the professional practice of the practitioner at such office, and where no supplies of controlled dangerous substances are maintained.

(c) No business premises shall be permitted to have multiple registrations of the same type, excluding the following:

(1) practitioners and mid-level practitioners.

(2) canine trainers and handlers.

(3) any business within its permitted transition period to a new business name, new address, or new ownership immediately prior to inactivation of the original registration occupying the business premises.

(4) hospitals with associated clinics and pharmacies.

(5) teaching institutions and scientific researchers.

(d) Business premises is defined as the entire parcel except where the context otherwise requires as determined exclusively by the Director. Where a business premises has been divided into suites, units, or other distinct areas, a separate registration shall be required for each unit that the registrant occupies pursuant to 63 O.S. § 2-302(J). Separate registrations shall not be required if the registrant owns or leases the entire business premises including all suites, units, or other distinct areas contained within the premises or where multiple units have been combined into a single larger unit with multiple rooms.

(1) Any single larger unit made up of a combination of multiple units must have restricted access so that the singular larger unit cannot be easily returned to separate units. If the rooms or smaller units can be easily returned to separate units, each unit shall require its own registration.

(2) Where a single larger unit registration is requested, an agent of the OBN may conduct a preregistration inspection to determine if it may be registered as a single unit and that the smaller units cannot be easily returned to separate units. Registrant operations must be clearly separate and distinct from other persons or operations.

Notes

Okla. Admin. Code § 475:10-1-4

Amended at 12 Ok Reg 2835, eff 7-15-95

Amended by Oklahoma Register, Volume 36, Issue 21, July 15, 2019, eff. 7/25/2019 Amended by Oklahoma Register, Volume 38, Issue 23, August 16, 2021, eff. 8/26/2021 Amended by Oklahoma Register, Volume 41, Issue 1, September 15, 2023, eff. 8/10/2023, exp. 9/14/2024 (Emergency) Amended by Oklahoma Register, Volume 41, Issue 21, July 15, 2024, eff. 8/4/2024 Amended by Oklahoma Register, Volume 42, Issue 1, September 16, 2024, eff. 8/16/2024, exp. 9/14/2025 (Emergency)